Indian firms set to launch new drugs in U.S.

05/12/2013 | Business Standard (India)

Despite a lengthy review process by the U.S. FDA, several Gujarat-based pharmaceutical firms are preparing to debut a range of new drugs in the U.S. market in the current fiscal year. Alembic Pharmaceuticals says it has submitted 57 abbreviated new-drug applications and already launched 15 new products. Intas Pharma anticipates introducing about 10 to 15 new drug products in the U.S. in the areas of chronic diseases and oncology.

View Full Article in:

Business Standard (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ